175 related articles for article (PubMed ID: 36337899)
1. The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.
Nezami Z; Holm H; Ohlsson M; Molvin J; Korduner J; Bachus E; Zaghi A; Dieden A; Platonov PG; Jujic A; Magnusson M
Front Cardiovasc Med; 2022; 9():982871. PubMed ID: 36337899
[TBL] [Abstract][Full Text] [Related]
2. Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients-The HARVEST-Malmö Study.
Zaghi A; Holm H; Korduner J; Dieden A; Molvin J; Bachus E; Jujic A; Magnusson M
Front Cardiovasc Med; 2022; 9():843029. PubMed ID: 35265689
[TBL] [Abstract][Full Text] [Related]
3. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
4. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
[TBL] [Abstract][Full Text] [Related]
5. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
6. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
7. Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction.
Mercer BN; Koshy A; Drozd M; Walker AMN; Patel PA; Kearney L; Gierula J; Paton MF; Lowry JE; Kearney MT; Cubbon RM; Witte KK
J Am Heart Assoc; 2018 Oct; 7(20):e009770. PubMed ID: 30371286
[TBL] [Abstract][Full Text] [Related]
8. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.
Inciardi RM; Giugliano RP; Claggett B; Gupta DK; Chandra A; Ruff CT; Antman EM; Mercuri MF; Grosso MA; Braunwald E; Solomon SD;
Eur J Heart Fail; 2019 Dec; 21(12):1571-1579. PubMed ID: 31777160
[TBL] [Abstract][Full Text] [Related]
9. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
[TBL] [Abstract][Full Text] [Related]
11. Galectin 3 and incident atrial fibrillation in the community.
Ho JE; Yin X; Levy D; Vasan RS; Magnani JW; Ellinor PT; McManus DD; Lubitz SA; Larson MG; Benjamin EJ
Am Heart J; 2014 May; 167(5):729-34.e1. PubMed ID: 24766984
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation.
Fu X; Iglesias-Álvarez D; García-Campos A; Martínez-Monzonís MA; Almenglo C; Martinez-Cereijo JM; Reija L; Fernandez ÁL; Gonzalez-Juanatey JR; Rodriguez-Manero M; Eiras S
J Cardiovasc Transl Res; 2024 Feb; 17(1):13-23. PubMed ID: 37878196
[TBL] [Abstract][Full Text] [Related]
13. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation.
Pandey A; Kim S; Moore C; Thomas L; Gersh B; Allen LA; Kowey PR; Mahaffey KW; Hylek E; Peterson ED; Piccini JP; Fonarow GC;
JACC Heart Fail; 2017 Jan; 5(1):44-52. PubMed ID: 28034376
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma levels of NT-proBNP, Troponin T and GDF-15 are driven by persistent AF and associated comorbidities: Data from the AF-RISK study.
Meems LMG; Artola Arita V; Velt M; Dudink EAMP; Crijns HJGM; Van Gelder IC; Rienstra M
Int J Cardiol Heart Vasc; 2022 Apr; 39():100987. PubMed ID: 35281756
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
Aulin J; Hijazi Z; Lindbäck J; Alexander JH; Gersh BJ; Granger CB; Hanna M; Horowitz J; Lopes RD; McMurray JJV; Oldgren J; Siegbahn A; Wallentin L;
Am Heart J; 2022 Sep; 251():13-24. PubMed ID: 35569564
[TBL] [Abstract][Full Text] [Related]
16. Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation.
Sonmez O; Ertem FU; Vatankulu MA; Erdogan E; Tasal A; Kucukbuzcu S; Goktekin O
Med Sci Monit; 2014 Mar; 20():463-70. PubMed ID: 24651058
[TBL] [Abstract][Full Text] [Related]
17. The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure.
Santema BT; Chan MMY; Tromp J; Dokter M; van der Wal HH; Emmens JE; Takens J; Samani NJ; Ng LL; Lang CC; van der Meer P; Ter Maaten JM; Damman K; Dickstein K; Cleland JG; Zannad F; Anker SD; Metra M; van der Harst P; de Boer RA; van Veldhuisen DJ; Rienstra M; Lam CSP; Voors AA
Clin Res Cardiol; 2020 Mar; 109(3):331-338. PubMed ID: 31263996
[TBL] [Abstract][Full Text] [Related]
18. Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure.
Tan ESJ; Chan SP; Liew OW; Chong JPC; Leong GKT; Yeo DPS; Ong HY; Jaufeerally F; Yap J; Sim D; Ng TP; Ling LH; Lam CSP; Richards AM
Clin Chem; 2021 Jan; 67(1):216-226. PubMed ID: 33279970
[TBL] [Abstract][Full Text] [Related]
19. High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients.
Sun LY; Qu X; Chen LZ; Chen XX; Zheng GS; Wang ZT; Huang WJ; Zhou H
Heart Vessels; 2017 Dec; 32(12):1506-1512. PubMed ID: 28689282
[TBL] [Abstract][Full Text] [Related]
20. Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
Huxley RR; Lopez FL; MacLehose RF; Eckfeldt JH; Couper D; Leiendecker-Foster C; Hoogeveen RC; Chen LY; Soliman EZ; Agarwal SK; Alonso A
PLoS One; 2013; 8(3):e59052. PubMed ID: 23554968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
